Skip to main content

Want a detailed portfolio tracker?

OverviewPerformanceMetricsFinancialsETFsIndustrySplitsCorrelations
Market CapEPSP/EP/SP/BSharesProfit MarginOperating MarginDebt to EquityRevenueEarningsEBITDAFree Cash FlowTotal DebtTotal AssetsROAROE

Inhibikase Therapeutics (IKT) Earnings (2020 - 2026)

Inhibikase Therapeutics (IKT) earnings from Mar 31, 2020 to Mar 31, 2026. The TTM Inhibikase Therapeutics (IKT) earnings is -$51M. You can adjust inflation or export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Annual Earnings

Quarterly Earnings

Inhibikase Therapeutics (IKT) Earnings CAGR table

PeriodCAGR
1 Year TTM+39.43%
3 Years TTM+41.76%
5 Years TTM+59.48%
All Time TTM+59.49%

Annual Earnings change of Inhibikase Therapeutics (IKT)

YearEarningsChange
2026-$16M-66.06%
2025-$48M+75.36%
2024-$28M+44.61%
2023-$19M+5.43%
2022-$18M+22.04%
2021-$15M+418.95%
2020-$2.85MN/A

Comparison Inhibikase Therapeutics (IKT) five years earnings CAGR with competitors

Inhibikase Therapeutics (IKT) five years earnings CAGR is 59.49%.

TickerNamefive years Earnings CAGRUpside
OKYOOKYO Pharma Ltd - New659.64%+1008.75%
GHRSGH Research PLC104.53%+75.70%
WHWKWhitehawk Therapeutics Inc101.60%+70.76%
NUVLNuvalent Inc - Class A95.20%+60.02%
CELCCelcuity Inc81.79%+37.48%
SMMTSummit Therapeutics Inc79.88%+34.26%
AAPGAscentage Pharma Group International78.94%+32.69%
VORVor Biopharma Inc78.15%+31.36%
RNAZTransCode Therapeutics Inc76.69%+28.90%
CMNDClearmind Medicine Inc76.57%+28.71%
ABVXAbivax72.69%+22.18%
UNCYUnicycive Therapeutics Inc69.16%+16.25%
BLTEBelite Bio Inc68.27%+14.75%
EXELExelixis Inc66.69%+12.09%
ARMPArmata Pharmaceuticals Inc65.74%+10.50%
ORKAARCA biopharma Inc64.21%+7.92%
XENEXenon Pharmaceuticals Inc64.02%+7.61%
JBIOJade Biosciences Inc63.91%+7.42%
PCVXVaxcyte Inc62.59%+5.21%
RVMDRevolution Medicines Inc61.25%+2.95%
TYRATyra Biosciences Inc61.13%+2.75%
VKTXViking Therapeutics Inc60.89%+2.34%
GLSIGreenwich LifeSciences Inc58.66%-1.41%
CRVSCorvus Pharmaceuticals Inc56.93%-4.30%
DRUGBright Minds Biosciences Inc56.50%-5.04%
SKYESkye Bioscience Inc55.14%-7.32%
SAVACassava Sciences Inc.54.99%-7.57%
EWTXEdgewise Therapeutics Inc53.35%-10.32%
ATXSAstria Therapeutics Inc52.07%-12.47%
NTRBNutriband Inc51.99%-12.62%
SNSESensei Biotherapeutics Inc51.15%-14.02%
CGTXCognition Therapeutics Inc50.70%-14.78%
RZLTRezolute Inc48.91%-17.79%
AKROAkero Therapeutics Inc48.79%-17.99%
CAPRCapricor Therapeutics Inc46.95%-21.09%
RVPHReviva Pharmaceuticals Holdings Inc46.40%-22.01%
VERAVera Therapeutics Inc - Class A45.98%-22.71%
IVAInventiva45.86%-22.91%
KYMRKymera Therapeutics Inc45.85%-22.94%
CRNXCrinetics Pharmaceuticals Inc44.30%-25.55%
CYTKCytokinetics Inc43.79%-26.40%
EYPTEyePoint Pharmaceuticals Inc43.59%-26.74%
DYNDyne Therapeutics Inc42.63%-28.34%
PHVSPharvaris NV42.31%-28.89%
MRVIMaravai LifeSciences Holdings Inc - Class A42.17%-29.12%
RXRXRecursion Pharmaceuticals Inc - Class A41.32%-30.54%
GLTOGalecto Inc40.78%-31.45%
TRDAEntrada Therapeutics Inc40.62%-31.73%
GOVXGeovax Labs Inc40.34%-32.19%
DSGNDesign Therapeutics Inc39.64%-33.38%
ABSIAbsci Corp39.21%-34.10%
INDPIndaptus Therapeutics Inc38.97%-34.50%
OLMAOlema Pharmaceuticals Inc38.93%-34.56%
VCELVericel Corp38.05%-36.04%
ANVSAnnovis Bio Inc37.85%-36.37%
CABACabaletta Bio Inc37.61%-36.79%
IRONDisc Medicine Inc36.96%-37.88%
DRTSAlpha Tau Medical Ltd36.85%-38.07%
ATHAAthira Pharma Inc36.80%-38.15%
AURAAura Biosciences Inc36.75%-38.23%
CGEMCullinan Oncology Inc36.35%-38.90%
IMVTImmunovant Inc36.31%-38.96%
LCTXLineage Cell Therapeutics Inc36.27%-39.04%
HYFTMindWalk Holdings Corp35.79%-39.85%
MRUSMerus N.V35.65%-40.08%
CLDXCelldex Therapeutics Inc34.81%-41.48%
IDYAIdeaya Biosciences Inc34.80%-41.52%
COGTCogent Biosciences Inc34.52%-41.98%
VSTMVerastem Inc34.08%-42.72%
SPRYARS Pharmaceuticals Inc33.59%-43.55%
SRRKScholar Rock Holding Corp33.31%-44.01%
BMEABiomea Fusion Inc33.06%-44.44%
ELDNEledon Pharmaceuticals Inc33.04%-44.46%
MDGLMadrigal Pharmaceuticals Inc32.58%-45.23%
PRAXPraxis Precision Medicines Inc32.20%-45.88%
BCYCBicycle Therapeutics Plc31.42%-47.19%
LGNDLigand Pharmaceuticals Inc - Class B31.37%-47.28%
RLAYRelay Therapeutics Inc31.36%-47.28%
GANXGain Therapeutics Inc31.30%-47.40%
VTGNVistaGen Therapeutics Inc31.19%-47.58%
REPLReplimune Group Inc31.16%-47.62%
NRIXNurix Therapeutics Inc30.82%-48.20%
ACHVAchieve Life Sciences Inc29.98%-49.61%
INSMInsmed Inc29.96%-49.65%
ADTXAditxt Inc29.36%-50.64%
RYTMRhythm Pharmaceuticals Inc29.30%-50.75%
STROSutro Biopharma Inc29.06%-51.15%
CRBUCaribou Biosciences Inc28.74%-51.69%
LRMRLarimar Therapeutics Inc28.22%-52.56%
TPSTTempest Therapeutics Inc27.96%-53.01%
LGVNLongeveron Inc - Class A27.64%-53.55%
PPCBPropanc Biopharma Inc27.60%-53.60%
TARSTarsus Pharmaceuticals Inc27.23%-54.23%
ARTLArtelo Biosciences Inc26.73%-55.08%
BNTCBenitec Biopharma Inc26.52%-55.42%
IBRXImmunityBio Inc26.44%-55.56%
LEXXLexaria Bioscience Corp26.13%-56.09%
RNXTRenovoRx Inc25.79%-56.64%
CPRXCatalyst Pharmaceuticals Inc25.10%-57.80%
OKURReneo Pharmaceuticals Inc - Class A25.05%-57.90%
QNRXQuoin Pharmaceuticals Ltd24.83%-58.26%
HOWLWerewolf Therapeutics Inc24.72%-58.46%
VANIVivani Medical Inc24.70%-58.48%
INCYIncyte Corp24.51%-58.80%
RAREUltragenyx Pharmaceutical Inc24.49%-58.84%
VRDNViridian Therapeutics Inc24.38%-59.02%
XOMAXOMA Royalty Corp24.15%-59.41%
STOKStoke Therapeutics Inc23.96%-59.72%
SVRASavara Inc23.86%-59.89%
XBITXBiotech Inc23.86%-59.89%
KURAKura Oncology Inc23.85%-59.92%
NCELNLS Pharmaceutics Ltd23.74%-60.10%
ERASErasca Inc23.60%-60.33%
TNGXTango Therapeutics Inc23.53%-60.45%
OCGNOcugen Inc23.49%-60.51%
CDTXCidara Therapeutics Inc23.42%-60.63%
INMBINmune Bio Inc23.32%-60.80%
SNDXSyndax Pharmaceuticals Inc23.22%-60.98%
GLUEMonte Rosa Therapeutics Inc22.80%-61.67%
ATYRAtyr Pharma Inc22.75%-61.76%
ARWRArrowhead Pharmaceuticals Inc22.39%-62.37%
NUVBNuvation Bio Inc - Class A22.32%-62.48%
MDWDMediWound Ltd22.18%-62.71%
KRROKorro Bio Inc22.01%-63.00%
FDMT4D Molecular Therapeutics Inc21.83%-63.30%
NTLAIntellia Therapeutics Inc21.57%-63.75%
DAWNDay One Biopharmaceuticals Inc21.52%-63.84%
CTXRCitius Pharmaceuticals Inc21.35%-64.11%
DMACDiaMedica Therapeutics Inc21.08%-64.57%
ANNXAnnexon Inc20.56%-65.44%
NGNENeoleukin Therapeutics Inc20.03%-66.33%
SLDBSolid Biosciences Inc19.56%-67.12%
TERNTerns Pharmaceuticals Inc19.16%-67.80%
DNTHDianthus Therapeutics Inc19.12%-67.87%
RGNXRegenxbio Inc19.03%-68.01%
KALVKalVista Pharmaceuticals Inc18.29%-69.27%
CBUSCibus Global Ltd. Class A18.28%-69.27%
TNXPTonix Pharmaceuticals Holding Corp18.21%-69.39%
SYRESpyre Therapeutics Inc17.63%-70.37%
CMPXCompass Therapeutics Inc17.44%-70.69%
TOVXTheriva Biologics Inc17.42%-70.72%
ELVNEnliven Therapeutics Inc17.34%-70.85%
OCULOcular Therapeutix Inc17.27%-70.98%
RCUSArcus Biosciences Inc17.06%-71.32%
CRDFCardiff Oncology Inc17.02%-71.39%
DWTXVirios Therapeutics Inc16.97%-71.48%
HALOHalozyme Therapeutics Inc16.42%-72.39%
AVTXAvalo Therapeutics Inc16.29%-72.61%
MNPRMonopar Therapeutics Inc16.12%-72.90%
XNCRXencor Inc15.87%-73.33%
HOOKHookipa Pharma Inc15.53%-73.90%
INABIN8bio Inc15.51%-73.93%
RNACCartesian Therapeutics Inc15.50%-73.95%
PRTCPureTech Health plc American Depositary Shares15.49%-73.96%
ATOSAtossa Therapeutics Inc15.37%-74.17%
ACETAdicet Bio Inc15.26%-74.36%
SERAgeX Therapeutics Inc15.15%-74.54%
PTIXProtagenic Therapeutics Inc15.13%-74.56%
PMVPPMV Pharmaceuticals Inc15.10%-74.62%
LXRXLexicon Pharmaceuticals Inc15.09%-74.64%
LTRNLantern Pharma Inc15.08%-74.65%
PALIPalisade Bio Inc15.08%-74.66%
RAPTRAPT Therapeutics Inc14.63%-75.41%
MBRXMoleculin Biotech Inc14.49%-75.65%
SLSSELLAS Life Sciences Group Inc14.43%-75.75%
TNYATenaya Therapeutics Inc14.36%-75.87%
AXSMAxsome Therapeutics Inc13.57%-77.20%
TENXTenax Therapeutics Inc13.35%-77.56%
ADVMAdverum Biotechnologies Inc13.34%-77.58%
CRVOCervoMed Inc13.04%-78.07%
MGTXMeiraGTx Holdings plc12.83%-78.44%
RNTXRein Therapeutics Inc12.78%-78.51%
ALTAltimmune Inc12.43%-79.11%
BRNSBarinthus Biotherapeutics Plc.12.40%-79.15%
IRDOcuphire Pharma Inc12.05%-79.75%
IMRNImmuron Ltd11.93%-79.94%
SLRXDecoy Therapeutics Inc11.88%-80.04%
DNAGinkgo Bioworks Holdings Inc - Class A11.74%-80.26%
RANIRani Therapeutics Holdings Inc Class A11.67%-80.38%
GRIGRI Bio Inc11.61%-80.49%
IPSCCentury Therapeutics Inc11.61%-80.49%
KROSKeros Therapeutics Inc11.52%-80.63%
DRMADermata Therapeutics Inc11.51%-80.66%
BBLGBone Biologics Corp11.48%-80.70%
PYXSPyxis Oncology Inc11.37%-80.88%
TARAProtara Therapeutics Inc11.11%-81.33%
ENTAEnanta Pharmaceuticals Inc11.09%-81.36%
HYPDEyenovia Inc10.90%-81.69%
LYRALyra Therapeutics Inc10.84%-81.78%
ORICORIC Pharmaceuticals Inc10.70%-82.02%
IBIOiBio Inc10.68%-82.05%
PTGXProtagonist Therapeutics Inc10.36%-82.58%
ALXOAlx Oncology Holdings Inc10.28%-82.71%
CBION/A10.04%-83.13%
SEERSeer Inc - Class A10.03%-83.14%
ARVNArvinas Inc9.82%-83.50%
RPTXRepare Therapeutics Inc9.51%-84.01%
VRTXVertex Pharmaceuticals Inc9.45%-84.12%
ACXPAcurx Pharmaceuticals Inc9.35%-84.28%
INVAInnoviva Inc9.22%-84.51%
PGENPrecigen Inc9.17%-84.59%
IMUXImmunic Inc9.13%-84.66%
IPHAInnate Pharma9.09%-84.72%
VALNValneva SE8.90%-85.04%
QUREuniQure N.V.8.55%-85.63%
OTLKOutlook Therapeutics Inc8.52%-85.68%
PLRXPliant Therapeutics Inc8.46%-85.77%
TSHATaysha Gene Therapies Inc8.44%-85.81%
FBRXForte Biosciences Inc8.34%-85.99%
CNSPCns Pharmaceuticals Inc8.23%-86.17%
MISTMilestone Pharmaceuticals Inc8.18%-86.25%
CLRBCellectar Biosciences Inc7.97%-86.61%
AVXLAnavex Life Sciences Corporation7.72%-87.03%
KODKodiak Sciences Inc7.70%-87.05%
CRSPCRISPR Therapeutics AG7.70%-87.05%
XFORX4 Pharmaceuticals Inc7.44%-87.50%
CLYMEliem Therapeutics Inc7.16%-87.96%
HUMAHumacyte Inc7.13%-88.01%
LITSLite Strategy Inc6.95%-88.32%
TRVITrevi Therapeutics Inc6.91%-88.38%
CCCCC4 Therapeutics Inc6.60%-88.90%
ATHEAlterity Therapeutics Ltd6.38%-89.28%
KPRXKiora Pharmaceuticals Inc6.30%-89.42%
CSBRChampions Oncology Inc6.28%-89.45%
RCKTRocket Pharmaceuticals Inc6.17%-89.63%
LSTALisata Therapeutics Inc5.99%-89.93%
IOVAIovance Biotherapeutics Inc5.92%-90.05%
PVLAPalvella Therapeutics Inc5.45%-90.84%
JSPRJasper Therapeutics Inc5.40%-90.93%
JAGXJaguar Health Inc5.38%-90.95%
SILOSILO Pharma Inc5.37%-90.98%
IFRXInflaRx N.V.5.31%-91.08%
BBIOBridgeBio Pharma Inc4.98%-91.63%
WVEWave Life Sciences Ltd4.85%-91.85%
CDXSCodexis Inc4.70%-92.10%
PRTAProthena Corporation plc3.99%-93.29%
HOTHHoth Therapeutics Inc3.94%-93.38%
PSTVPlus Therapeutics Inc3.86%-93.52%
EDSAEdesa Biotech Inc3.78%-93.65%
STTKShattuck Labs Inc3.56%-94.01%
GNTAGenenta Science SpA3.15%-94.71%
URGNUroGen Pharma Ltd2.70%-95.47%
VIRVir Biotechnology Inc2.55%-95.71%
PRLDPrelude Therapeutics Inc2.51%-95.78%
DBVTDBV Technologies2.49%-95.82%
MOLNMolecular Partners AG2.36%-96.03%
BIVIBioVie Inc - Class A2.19%-96.32%
PHIOPhio Pharmaceuticals Corp2.11%-96.46%
REGNRegeneron Pharmaceuticals Inc2.01%-96.62%
NBTXNanobiotix1.96%-96.70%
FULCFulcrum Therapeutics Inc1.87%-96.85%
ONCYOncolytics Biotech Inc1.80%-96.97%
SPRBSpruce Biosciences Inc1.66%-97.22%
ACRSAclaris Therapeutics Inc1.65%-97.22%
ACIUAC Immune SA1.58%-97.35%
CTMXCytomX Therapeutics Inc1.52%-97.44%
ATNMActinium Pharmaceuticals Inc1.43%-97.60%
ANIXAnixa Biosciences Inc1.33%-97.77%
NRSNNeuroSense Therapeutics Ltd1.18%-98.02%
CNTACentessa Pharmaceuticals plc1.08%-98.19%
PRQRProQR Therapeutics N.V0.91%-98.47%
MNOVMedicinova Inc0.68%-98.85%
SCNIScinai Immunotherapeutics Ltd0.24%-99.59%
KZRKezar Life Sciences Inc0.23%-99.62%
GALTGalectin Therapeutics Inc0.00%-99.99%